Adar Poonawalla

Last updated

Adar Poonawalla
Adar poonawalla and Cyrus Poonawalla at the 4th Asian Awards.jpg
Adar (on left) and Cyrus Poonawalla in 2014
Born (1981-01-14) 14 January 1981 (age 44)
CitizenshipIndian
Education The Bishop's School (Pune)
St Edmund's School Canterbury
Alma mater University of Westminster
Occupation Businessman
TitleCEO, Serum Institute of India
Chairman, Poonawalla Fincorp
Term2011–present
Spouse
Natasha Poonawalla
​
(m. 2006)​
[1]
Children2
Father Cyrus Poonawalla
Website www.adarpoonawalla.com

Adar Poonawalla (born 14 January 1981) is an Indian businessman. He is the chief executive officer of Serum Institute of India and Chairman of Poonawalla Fincorp. [2] [3] His father is Cyrus Poonawalla, founder of the Serum Institute of India. [4]

Contents

Personal life

Adar Poonawalla is the son of Cyrus Poonawala, a Parsi (Zoroastrian). He is married to Natasha Poonawalla and has two children. [1] [5] In December 2023, Poonawalla purchased the most expensive property in London worth Rs 1446 Crore. [6] [7]

Education

Adar Poonawalla was educated at The Bishop's School (Pune) and at the St Edmund's School Canterbury followed by the University of Westminster. [8]

Career

Poonawalla joined the Serum Institute of India in 2001, after graduating from university. Then exporting its products to 35 countries, Poonawalla concentrated on the company's international market, new products license and getting pre-qualified by the World Health Organization for supply to United Nations Agencies including UNICEF and PAHO. As of 2015, he has helped the company export its products to over 140 countries; 85 percent of its revenues are from overseas. [9] [10]

In 2011, he became the CEO. In 2012, he played a major role in the acquisition of Bilthoven Biologicals, a Netherlands-based government vaccine manufacturing company. [11] [12] Poonawalla is a board member of the GAVI Alliance, the global vaccine alliance. [13]

He initiated and launched Serum Institute's oral polio vaccine in 2014, which became a bestseller for the company. It was reported that he planned to expand the product portfolio to include vaccines for dengue, flu, and cervical cancer during the same year. [10] Presently he is the CEO of Serum Institute of India. [14]

On 31 May 2021, he was appointed as the chairman of Poonawalla Fincorp, [15] after acquiring a 66% stake in the financial services company. [16] [17]

In 2024, he acquired a 50% stake in Dharma Productions for ₹1,000 crore. [18]

Threats demanding COVID-19 vaccines

In an interview with The Times , Poonawalla declared that he left India for London because of threats demanding COVID-19 vaccines. [19] [20] Poonawalla also said that he will start COVID vaccine production outside India, in addition to the ongoing production in India. [21] [22] He was provided with 'Y' category security by the Indian government as the threats were made public. [23]

Philanthropy

In 2020, Serum Institute of India announced that it would donate $66 million to the University of Oxford to fund the creation of the Poonawalla Vaccines Research Building. [24] [25]

Awards

Related Research Articles

<span class="mw-page-title-main">Mukesh Ambani</span> Indian billionaire businessman (born 1957)

Mukesh Dhirubhai Ambani is an Indian billionaire and businessman who is the chairman and managing director of Reliance Industries. He is the richest person in Asia and 9th richest in the world.

<span class="mw-page-title-main">Biocon</span> Indian multinational biopharmaceutical company

Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.

<span class="mw-page-title-main">Larsen & Toubro</span> Indian multinational conglomerate company

Larsen & Toubro Limited, abbreviated as L&T, is an Indian multinational conglomerate, with interests in industrial technology, heavy industry, engineering, construction, manufacturing, power, information technology, military and financial services. It is headquartered in Mumbai, Maharashtra.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Kumar Mangalam Birla</span> Indian industrialist

Kumar Mangalam Birla is an Indian billionaire businessman. He is the chairman of the Aditya Birla Group, one of the largest conglomerates in India. He is the chancellor of the Birla Institute of Technology & Science, Pilani and ex-chairman of Indian Institute of Management Ahmedabad. In 2023, Birla received the Padma Bhushan, the third highest civilian honour in India.

<span class="mw-page-title-main">Dharma Productions</span> Indian film production company

Dharma Productions Pvt. Ltd. is an Indian film production and distribution company established by Yash Johar in 1979. It was taken over in 2004, after his death, by his son, Karan Johar. Based in Mumbai, it mainly produces and distributes Hindi films.

Serum Institute of India (SII) is an Indian multinational biotechnology and biopharmaceuticals company, based in Pune. It is the world's largest manufacturer of vaccines by volume. It was founded by Cyrus Poonawalla in 1966 and is a part of Cyrus Poonawalla Group.

Pankaj Ramanbhai Patel is an Indian billionaire businessman, and the chairman of Zydus Lifesciences, the fifth largest pharmaceutical company in India.

<span class="mw-page-title-main">Cyrus S. Poonawalla</span> Indian billionaire businessman

Cyrus S. Poonawalla is an Indian billionaire businessman, and the chairman and managing director of the Cyrus Poonawalla Group, which includes the Serum Institute of India, an Indian biotech company which is the largest vaccine manufacturer in the world and Poonawalla Fincorp a leading NBFC in India. In 2022, he is ranked as the 4th richest person in India on Forbes India rich list with a net worth of $24.3 billion. He is ranked number 1 on the Hurun Global Healthcare Rich List 2022.

Poonawalla Fincorp Limited is an Indian non-banking financial company (NBFC) engaged in consumer and MSME financing. It is headquartered in Pune and is part of the Cyrus Poonawalla Group.

FSN E-Commerce Ventures Ltd, d/b/a Nykaa, is an Indian retail company, headquartered in Mumbai. It sells beauty, wellness and fashion products through its website, mobile app and over 100 physical stores. In 2020, it became the first Indian unicorn startup headed by a woman.

Lincoln House, owned by billionaire Cyrus Poonawalla, is a 50,000 sq foot heritage property located at 78, Bhulabhai Desai Road, in the billionaires row of Mumbai, India.

Sekharipuram Narayanan Subrahmanyan is an Indian businessman who is currently serving as the chairman and managing director of Larsen & Toubro, an Indian multinational conglomerate. He took over as the MD from A. M. Naik on 1 July 2017. He is also the Vice Chairman on the Boards of LTIMindtree and L&T Technology Services, Chairman of L&T Metro Rail (Hyderabad) Limited and Director and Chairperson of L&T Finance Holdings Ltd.

The first case of the COVID-19 pandemic was confirmed in the Indian state of Odisha on 16 March 2020. The state has confirmed 10,00,084 cases, including 9,497 active cases, 9,83,245 recoveries, and 7,289 deaths as of 21 August 2021.

<span class="mw-page-title-main">COVID-19 pandemic in Mizoram</span> Ongoing COVID-19 viral pandemic in Mizoram, India

The first case of the COVID-19 pandemic in India was reported on 30 January 2020. Slowly, the pandemic spread to various states and union territories including the state of Mizoram. The first case was recorded in this region on 24 March 2020, and the first death was recorded on 28 October 2020.

Events in the year 2021 in India for real time basis.

<span class="mw-page-title-main">COVID-19 vaccination in India</span> Immunisation programme against COVID-19 in India

India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023, India has administered over 2.2 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines. In India, 95% of the eligible population (12+) has received at least one shot, and 88% of the eligible population (12+) is fully vaccinated.

<span class="mw-page-title-main">Vaccine Maitri</span> Vaccination initiative by the Indian government

Vaccine Maitri is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around the world. The government started providing vaccines from 20 January 2021. As of 21 February 2022, India had delivered around 16.29 crore doses of vaccines to 96 countries. Of these, 1.43 crore doses were gifted to 98 countries by the Government of India. The remaining 10.71 crore were supplied by the vaccine producers under its commercial and 4.15 crore were supplied by COVAX obligations. In late March 2021, the Government of India temporarily froze exports of the Covishield, citing India's own COVID crisis and the domestic need for these vaccines. The Health Minister of India, Mansukh Mandaviya announced in September that India will resume the export of vaccines from October to the rest of the world.

Dr. Krishna Ella is an Indian scientist and entrepreneur. He is the founder and Executive Chairman of Bharat Biotech. Ella and his company were responsible for developing India's own COVID-19 vaccine, Covaxin, World's 1st clinically proven conjugated Typhoid Vaccine, TypbarTCV and ROTAVAC.

<span class="mw-page-title-main">Suresh Jadhav (biotechnology executive)</span> Indian biotechnology executive (died 2021)

Suresh Jadhav was an Indian biotechnology executive and a key member of the Indian vaccine manufacturing industry. At the Serum Institute of India (SII) he led the development and introduction of the Meningococcal A conjugate vaccine to Sub-Saharan Africa and the production of the COVID-19 vaccine at SII, including the ones marketed as Covishield.

References

  1. 1 2 "Farm fatale: When billionaire Adar Poonawala's glamourous [sic] wife Natasha posed with a horse!". The Economic Times. 28 October 2016. Retrieved 13 December 2018.
  2. ↑ "The Real Vaccine Billionaires of India Maharashtra". Bloomberg. 11 August 2020 – via www.bloomberg.com.
  3. ↑ Shukla, Saloni (27 December 2022). "Poonawalla Fincorp well capitalised to touch Rs 50,000 cr AUM in 5 years". The Economic Times.
  4. ↑ Narayan, Adi (15 June 2011). "Billionaire-Led Indian Drugmaker's Vaccine Beats Glaxo in Study". Bloomberg Business. Retrieved 2 September 2015.
  5. ↑ "Natasha children s Navjot ceremony in Golden saree..." indiaherald.com. 16 May 2023. Retrieved 14 July 2023.
  6. ↑ "Poonawalla buys the priciest property in London worth Rs 1446 Crore". BruTimes.
  7. ↑ "Adar Poonawalla strikes a deal to buy London's most expensive house of the year worth ₹1446 crore". Hindustan Times. 12 December 2023.
  8. ↑ "Westminster alumnus-led vaccine manufacturer set to play a leading role in large scale production of coronavirus vaccine | University of Westminster, London". www.westminster.ac.uk. Retrieved 13 September 2020.
  9. ↑ Dangor, Kimi (6 June 2005). "The private tycoons". India Today. Retrieved 2 September 2015.
  10. 1 2 "How Cyrus Poonawalla's son, Adar Poonawalla is boldly changing course of the family business". The Economic Times. 11 April 2014. Archived from the original on 12 April 2014. Retrieved 13 August 2015.
  11. ↑ "Serum acquires Dutch firm Bilthoven for over Rs. 550 crore". Business Line. 4 July 2012. Retrieved 20 August 2015.
  12. ↑ "Serum Institute of India buys Dutch vaccine maker for $40.3 mn". NDTV Profit. 4 July 2012. Retrieved 20 August 2015.
  13. ↑ "Governance". www.gavi.org. 10 July 2023.
  14. ↑ "Serum Institute of India | Manufacturer of Vaccines & immuno-biologicals - GMP Vaccine Manufacturer". www.seruminstitute.com. Retrieved 22 April 2024.
  15. ↑ "Adar Poonawalla, Chairman Of Poonawalla Fincorp On ET Now Exclusive | The Interview". Times Now. 12 June 2023. Retrieved 22 April 2024.
  16. ↑ Gopakumar, Gopika (31 May 2021). "Adar Poonawalla appointed as chairman of Magma Fincorp". mint.
  17. ↑ Karmali, Naazneen. "India's 10 Richest Billionaires 2021". Forbes. Retrieved 23 July 2021.
  18. ↑ "Karan Johar's Dharma Productions sells 50% stake to Adar Poonawalla for ₹1,000 crore". The Hindu. 21 October 2024. Retrieved 17 January 2025.
  19. ↑ Kapur, Manavi (May 2021). "India's vaccine czar has left the country for the UK due to "unprecedented" threats". Quartz.
  20. ↑ "'Getting aggressive calls from powerful people': Serum CEO Adar Poonawalla on vaccine pressure | India News - Times of India". The Times of India. May 2021.
  21. ↑ "Serum chief flies to UK to escape 'threats' from CMs, corporates biggies". www.telegraphindia.com.
  22. ↑ "'Everything falls on my shoulders': Adar Poonawalla on vaccine pressure in India". mint. 1 May 2021.
  23. ↑ "Centre grants Y category security to Serum Institute CEO Adar Poonawalla amid threats over Covishield supplies". www.businesstoday.in. 29 April 2021.
  24. ↑ "India's billionaire Poonawallas pledge $66m to Oxford University". www.aljazeera.com. Retrieved 21 December 2021.
  25. ↑ "£50m funding for Poonawalla Vaccines Research Building at Oxford University | University of Oxford". www.ox.ac.uk. 15 December 2021. Retrieved 21 December 2021.
  26. ↑ "GQ Awards Men of the Year – Philanthropist". GQ India. 27 September 2016. Retrieved 27 September 2016.
  27. ↑ "Got Humanitarian Endeavour Award". Biz Asia. 28 March 2017. Retrieved 28 March 2017.
  28. ↑ "Adar Poonawalla is Indian of the Year in CSR Business Category". CNN News 18. Retrieved 30 November 2017.
  29. ↑ "CM Devendra Fadnavis presents the Business Leader of the Year Award to Adar Poonawala". Femina. Retrieved 27 February 2018.
  30. ↑ "Adar Poonawalla received the CNBC Asia's award for Corporate Social Responsibility of the year". Livemint. Retrieved 7 April 2018.
  31. ↑ "Adar Poonawalla | 2020 40 under 40 in Health". Fortune. Retrieved 13 September 2020.
  32. ↑ "ET Awards: Adar Poonawalla, doing India proud with a small jab, and a big gamble". The Economic Times. 8 February 2021.
  33. ↑ "PM Modi, Mamata, Adar Poonawalla among Time Magazine's 100 'most influential people of 2021'". The Indian Express . 15 September 2021. Retrieved 10 November 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.